Vericel Corp VCEL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/02/24 EDT
47.88quote price arrow up+0.80 (+1.70%)
Volume
329,618
52 week range
30.18 - 53.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close47.88
  • 52 Week High53.05
  • 52 Week High Date04/01/24
  • 52 Week Low30.18
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap2.316B
  • Shares Out48.38M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change34.46

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close47.88
  • 52 Week High53.05
  • 52 Week High Date04/01/24
  • 52 Week Low30.18
  • 52 Week Low Date10/13/23
  • Market Cap2.316B
  • Shares Out48.38M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change34.46

RATIOS/PROFITABILITY

  • EPS (TTM)-0.07
  • P/E (TTM)-700.00
  • Fwd P/E (NTM)903.40
  • EBITDA (TTM)-1.715M
  • ROE (TTM)-1.52%
  • Revenue (TTM)197.516M
  • Gross Margin (TTM)68.64%
  • Net Margin (TTM)-1.61%
  • Debt To Equity (MRQ)0.04%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vericel Corp

 

Content From Our Affiliates

Profile

MORE
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone...
Robert Zerbe
Independent Chairman of the Board
Dominick Colangelo
President, Chief Executive Officer, Director
Michael Halpin
Chief Operating Officer
Joseph Mara
Chief Financial Officer
Address
64 Sidney St
Cambridge, MA
02139-4170
United States

Top Peers

SYMBOLLASTCHG%CHG
ARVN
Arvinas Inc
32.43-0.05-0.15%
TGTX
TG Therapeutics Inc
16.42+0.54+3.40%
ARWR
Arrowhead Pharmaceuticals Inc
24.13+0.96+4.14%
DNLI
Denali Therapeutics Inc
16.81+0.65+4.02%
RYTM
Rhythm Pharmaceuticals Inc
40.98-0.45-1.09%